These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Some data on the state of sedimentation in the light sedimentation reaction in urine]. DARIALASHVILI AA Lab Delo; 1962 Feb; 8():47-9. PubMed ID: 13883567 [No Abstract] [Full Text] [Related]
3. In Vivo Intracerebral Administration of α-Ketoisocaproic Acid to Neonate Rats Disrupts Brain Redox Homeostasis and Promotes Neuronal Death, Glial Reactivity, and Myelination Injury. Zemniaçak ÂB; Ribeiro RT; Pinheiro CV; de Azevedo Cunha S; Tavares TQ; Castro ET; Leipnitz G; Wajner M; Amaral AU Mol Neurobiol; 2024 May; 61(5):2496-2513. PubMed ID: 37910283 [TBL] [Abstract][Full Text] [Related]
4. Alternative sources of valine and isoleucine for prompt reduction of plasma leucine in maple syrup urine disease patients: A case series. Ziadlou M; MacDonald A JIMD Rep; 2022 Nov; 63(6):555-562. PubMed ID: 36341173 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease. Scaini G; Tonon T; Moura de Souza CF; Schuck PF; Ferreira GC; Quevedo J; Neto JS; Amorim T; Camelo JS; Margutti AVB; Hencke Tresbach R; Sperb-Ludwig F; Boy R; de Medeiros PFV; Schwartz IVD; Streck EL J Inherit Metab Dis; 2018 May; ():. PubMed ID: 29740775 [TBL] [Abstract][Full Text] [Related]
6. Interrupting the mechanisms of brain injury in a model of maple syrup urine disease encephalopathy. Zinnanti WJ; Lazovic J J Inherit Metab Dis; 2012 Jan; 35(1):71-9. PubMed ID: 21541722 [TBL] [Abstract][Full Text] [Related]
7. New developments in the treatment of hyperammonemia: emerging use of carglumic acid. Daniotti M; la Marca G; Fiorini P; Filippi L Int J Gen Med; 2011 Jan; 4():21-8. PubMed ID: 21403788 [TBL] [Abstract][Full Text] [Related]
8. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241 [TBL] [Abstract][Full Text] [Related]
10. Maple syrup urine disease in five hereford calves in ontario. Baird JD; Wojcinski ZW; Wise AP; Godkin MA Can Vet J; 1987 Aug; 28(8):505-11. PubMed ID: 17422842 [TBL] [Abstract][Full Text] [Related]
11. [MAPLE SYRUP DISEASE WITH FAMILIAL INCIDENCE]. DIEZEL PB; MARTIN K Virchows Arch Pathol Anat Physiol Klin Med; 1964 May; 337():425-45. PubMed ID: 14217031 [No Abstract] [Full Text] [Related]
12. Recent work on phenylketonuria and maple syrup urine disease (leucinosis). WOOLF LI Proc R Soc Med; 1962 Oct; 55(10):824-6. PubMed ID: 14001839 [No Abstract] [Full Text] [Related]
13. Maple syrup urine disease. PATRICK AD Arch Dis Child; 1961 Jun; 36(187):269-72. PubMed ID: 13733337 [No Abstract] [Full Text] [Related]
15. [On the effect of dietetic prophylaxis on the myelogenesis of leucionsis (maple syrup urine disease)]. Linneweh F; Solcher H Klin Wochenschr; 1965 Sep; 43(17):926-30. PubMed ID: 5863558 [No Abstract] [Full Text] [Related]
16. Spongy degeneration in the white matter of the central nervous system in the newborn: pathological findings in three infants, one with hyperglycinaemia. Anderson JM J Neurol Neurosurg Psychiatry; 1969 Aug; 32(4):328-37. PubMed ID: 4185340 [No Abstract] [Full Text] [Related]
17. Spongy degeneration of the central nervous system (van Bogaert-Bertrand type?) in a newborn infant. A light and electron microscopic study. Towfighi J; Friedman Z; Maisels MJ Acta Neuropathol; 1977 Mar; 37(3):267-70. PubMed ID: 855648 [TBL] [Abstract][Full Text] [Related]